An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)

Clinical trial NCT01631513 · WITHDRAWN

Trial details

NCT number: NCT01631513
Sponsor: Janssen Scientific Affairs, LLC
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Pain Chronic Back Pain Chronic Low Back Pain Osteoarthritis Pain In The Hip or Knee

Start date: 2012-08-01
Primary completion: 2012-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.